Abstract
58 patients with locally advanced or relapsed squamous cell heal and neck cancer were treated on 5 consecutive days with DDP 20 mg/m2/d IV-push, followed by CF 100 mg/m2/d IV-bolus and Fura 400 mg/m2/d IV-push 60 minutes later. Treatment was recycled on day 22(−29), according to toxicity. CF was added to the widely used DDP/Fura combination, because recent studies showed enhancement of Fura-activity by CF. 45/58 patients had no prior therapy and 13/58 pts were relapsed after chemotherapy and/or radiation therapy. All patients were evaluable for toxicity and response. After 3 courses of induction chemotherapy 23/45 pts in the previously untreated group had a complete response (CR); 20/45 a partial response(PR), 2/45 were restaged as no change (CR + PR: 95%). Induction chemotherapy was followed by radical surgery and postoperative radiation therapy. In the pretreated group 4/13 pts had a complete response; 6/13 a partial response; no change in 3/13 pts. Median duration of remission (MDR) has not been reached in the primarily untreated group, whereas in pretreated patients the MDR was 3.8 months (range 2.3–11.7 months). Hematologic and gastrointestinal toxicity was substantial but manageable and therapy was performed on an outpatient basis. The combination of DDP, CF and Fura has high activity in untreated and pretreated head and neck cancer patients. The obtained results are comparable to the widely used DDP/Fora continuous infusion regimen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120 hour 5-FU infusion and Cisplatinum. Cancer 55: 1123–1128 (1985)
Kish JA, Weaver A, Jacobs J, et al: Cisplatinun and 5-Fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1819–1824 (1984)
Kish JA, Ensley JF, Jacobs J et al: A randanized trial of Cisplatinum (CACP) + 5-Fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56: 2740–2744 (1985)
Evans RM, Laskin JD, Hakala MT: Effect of excess folates and deoxyinosine on the activity and site of action of 5-Fluorouracil. Cancer Res. 41: 3288–3295 (1981)
Yin MB, Zakrzewski SF, Hakala MT: Relationship of cellular folate cofactor pools to activity of 5-Fluorouracil. Mol. Pharmacol. 23: 190–197 (1984)
Danenberg PV, Denenberg KD: Effect of 5,10-ffethylenetetrahydrofolate and the dissociation of 5-fluoro-2’-deoxyuridylate from thymidylate synthetase: Evidence for an ordered mechanism. Biochemistry 17: 4018–4024 (1978)
Iockshin A., Danenberg PV: Biochemical factors affecting the tightness of 5-fluorodeoxyundylate binding of human thymidylate synthetase. Biochem. Pharmacol. 30: 247–257 (1980)
Scanlon KJ, Nee Dels C, Lu Y, et al: Biochemical basis for Cisplatinum and 5-Fluorouracil synergism in human tumors. Proc. Pm. Assoc. Cancer. Res., 26: 1156 (1986)
Machover D, Goldscianidt E, Chollet P et al: Treatment of advanced colorectal and gastric adenocarcinana with 5-FU and high-dose Folinic Acid. J. Clin. Oncol. 4: 685–696 (1986)
Marini G, Simoncini E, Zaniboni A, et al: 5-Fluorouracil and high-dose folinic acid as salvage treatment of advance breast cancer: An update. Oncology 44: 336–340 (1987)
Bertrand M, Doroshcw JH, Multhauf P, et al: High-dose continuous infusion folinic acid and 5-fluorouracil in patients with advanced colorectal cancer. A phase II study. J. Clin. Oncol. 4: 1058–1061 (1986)
Allegra CJ, Chabner BA, Sholar PW et al: Preliminary results of a phase-II-trial for the treatment of metastatic breast cancer with 5-Fluorouracil and Leucovorin. NCI Monographs, 5: 199–202 (1987)
Vokes EE, Choi KE, Schilsky RL, et al: Cis-Platin, Fluorouracil and high dose Leucovorin for recurrent or metastatic head and neck cancer. J. Clin. Oncol. 6: 618–626 (1988)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Loeffler, T.M., Lindemann, J., Luckhaupt, H., Rose, K.G., Hausamen, T.U. (1988). Chemotherapy of Advanced and Relapsed Squamous Cell Cancer of the Head and Neck with Split-Dose Cisplatinum (DDP), 5-Fluorouracil (Fura) and Leucovorin (CF). In: Rustum, Y., McGuire, J.J. (eds) The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. Advances in Experimental Medicine and Biology, vol 244. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-5607-3_29
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5607-3_29
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-5609-7
Online ISBN: 978-1-4684-5607-3
eBook Packages: Springer Book Archive